<unk>  is an enzyme that is FDA approved for the treatment of patients having congenital deficiency of α1–PI with clinically evident emphysema.   Common adverse reactions include chest discomfort, dizziness, headache, cough, sinusitis, upper respiratory infection.
Alpha-1 proteinase inhibitor
Fibrinolysin
Pentostatin
Thromboxane
Pentosan polysulfate
Elcatonin
Antimicrobial peptides
Prostaglandin F2alpha